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Abstract
Aim. To determine the adequacy of initial nurse independent prescribing
education and identify continuing professional development and clinical
governance strategies in place for non-medical prescribing.
Background. In 2006, new legislation in England enabled nurses with an
independent prescribing qualification to prescribe, within their competence. In 2006,
non-medical prescribing policies released by the Department of Health outlined
the recommendations for education, continuing professional development and
governance of non-medical prescribing; however, there was no evidence on a national
scale about the extent of implementation and effectiveness of these strategies.
Design. National surveys of: (i) nurse independent prescribers; and (ii) non-
medical prescribing leaders in England.
Methods. Questionnaire surveys (August 2008–February 2009) covering
educational preparation, prescribing practice (nurse independent prescribers) and
structures/processes for support and governance (non-medical prescribing leaders).
Results. Response rates were 65% (976 prescribers) and 52% (87 leaders). Most
nurses felt their prescribing course met their learning needs and stated course
outcomes and that they had adequate development and support for prescribing to
maintain patient safety. Some types of community nurse prescribers had less access
to support and development. The prescribing leaders reported lacking systems to
ensure continuity of non-medical prescribing and monitoring patient experience.
Conclusion. Educational programmes of preparation for nurse prescribing were
reported to be operating satisfactorily and providing fit-for-purpose preparation
for the expansion to the scope of nurse independent prescribing. Most clinical
governance and risk management strategies for prescribing were in place in
primary and secondary care.
Keywords: clinical governance, continuing professional development, non-medical
prescribing, nurse education
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Introduction
Non-medical prescribing is now well incorporated into the
English health service; this study reports findings around pol-
icy implementation and the education of nurses as this initia-
tive has developed. As international healthcare systems look
to set up or modify existing frameworks for non-medical
prescribing it is logical to critique the UK model of training,
competency standards and continuing professional develop-
ment (CPD) (Weeks et al. 2010, Wilkinson 2011) as it has
been described as ‘the most radical, unrestricted model of
non-medical prescribing (NMP) anywhere in the
world’(Kroezen et al. 2011). Educational preparation has
been the subject of particular debate since the UK pro-
gramme is shorter than other countries such as America or
New Zealand which require an advanced nursing practice
course to prescribe (Kroezen et al. 2011). Nurse prescribing
has been well integrated in America for decades, however, it
is in its infancy in countries such as New Zealand and Aus-
tralia (Elsom et al. 2008, New Zealand Ministry of Health
2013). Therefore, various lessons can be learnt from the UK
model around education and implantation. For example,
would a short prescribing course suffice in America? Or how
have rural community nurses integrated into the health care
team – can this assist New Zealand and Australia where
NMP is on the threshold of rapid expansion?
Background
NMP was introduced to give patients quicker access to
medicines, improve access to services and make better use
of health professionals skills (Department of Health 2011).
Nurses in the UK have had various forms of prescribing
rights since 1994, when a district nurse/health visitor pre-
scribing formulary was introduced. In 2002, an extended
formulary was created, followed by supplementary prescrib-
ing in 2003, which allowed nurses to prescribe in partner-
ship with a medical prescriber. In 2006, these forms of
prescribing were superseded. Nurse independent/supplemen-
tary prescribing permitted nurses to prescribe across the
formulary (a list of available medicines in England) with
the exception of some controlled drugs (at the time of the
study). This enables nurses to complete a whole episode of
care for any patient from diagnosis, to treatment and fol-
low-up either independently or in conjunction with a medi-
cal prescriber (Department of Health 2011). Since 2006,
many Universities across the UK have set up courses to
train nurses for independent prescribing roles; Table 1
below outlines the characteristics of these courses. All
courses have to be accredited by the nursing regulator, the
Nursing & Midwifery Council (NMC).
Safe and effective prescribing is taught in all courses and
is an expected core competency of any new prescriber;
however, health professional graduates of all disciplines
often lack confidence in this (Maxwell & Walley 2003, He-
aton et al. 2008). For example, concerns have previously
been expressed about the adequacy of nurses’ pharmacol-
ogy and clinical skills training and hence their confidence
and readiness to practice (Bradley et al. 2006, Bewley
2007). Little is known around educational preparedness of
nurse independent prescribers (NIP) since the changes in
2006 (Department of Health 2011). Earlier nurse indepen-
dent prescribing studies have indicated the importance of
prescriber support and CPD after qualifying as a prescriber
and have reported inconsistencies across healthcare
employer organizations (Maxwell & Walley 2003, Latter
et al. 2005, Stewart et al. 2012).
National Health Service (NHS) Trusts are organizations
that provide services on behalf of the English NHS. They
are responsible for the clinical governance, a systematic
approach to maintaining and improving the quality of
patient care (Department of Health 1998). Each NHS Trust
is expected to have a ‘non-medical prescribing (NMP) lead’,
a leader who is responsible for the safe implementation of
NMP through organizational arrangements and national
and local policies. Policy underpinning NMP outlines strate-
gies for the development and implementation of NMP
including the need for: stakeholder and patient/public
awareness initiatives, internal arrangements for monitoring
NMP prescribing, mechanisms/criteria for applications for
training to be a NMP and placement of nurses for training,
processes for obtaining prescription pads, distributing any
relevant policies, procedures and any other relevant local
information (Department of Health 2006). However, at the
time of this study there was no published research or
national data on these arrangements or the extent to which
this guidance was being followed in practice.
The study
Aims
The aims of this research, which formed part of a larger eval-
uation of non-medical prescribing in England commissioned
by the Department of Health (Latter et al. 2010) were to:
● determine the adequacy of educational preparation for
nurse independent prescribers
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● identify continuing professional development, clinical
governance and professional regulation strategies in place
in NHS Trust in England
While non-medical prescribing takes place across the UK,
this paper only focuses on results from nurse independent
prescribers in England. Results for pharmacist independent
prescribers in England can be found elsewhere (Latter et al.
2010).
Design
Table 1 Characteristics of nurse independent prescribing courses in the UK (Department of Health 2006).
Independent nurse prescribing




-be a registered nurse/midwife/specialist community public health nurse
-have a minimum of 3 years practice experience
-be deemed competent by an employer to undertake a patient history,
clinical assessment and diagnosis and sufficient knowledge to apply prescribing
principles to their clinical area
-identify; a clinical need for the prescribing role,
access to a budget to meet the costs of their prescriptions on completion of
the course (primary healthcare nurses only), access to continuing professional
development (CPD) opportunities (determined by employer)
-be able to demonstrate appropriate numeracy skills
-be able to prove they have the ability to study at Bachelor’s degree level or equivalent
-have the support of employer and lead nurse
-have an eligible medical supervisor
Course academic standard Represents a qualification level that shares similar expectations of attainment to
a Bachelor’s degree*
Type of learning Taught or distance learning (must have at least 8 face to face taught days and
10 days of protected learning)
Length of course -26 days minimum + 12 days supervised learning in practice
-Must complete within 1 year
Type of course -Can be stand-alone or run alongside a clinical course (e.g. nurse practitioner)
-Can be nurse only or mixed courses (e.g. complete the course with pharmacists
and allied health professional students)
Supervised practice Minimum 12 days. All students must have a Designated Medical Practitioner (DMP)
to supervise, guide and assess learning in practice
Course Components -Consultation, decision-making and therapy including referral
-Influences on and psychology of, prescribing
-Prescribing in a team context
-Clinical pharmacology, including the effects of co-morbidity
-Evidence based practice and clinical governance in relation to nurse prescribing
-Legal, policy and ethical aspects
-Professional accountability and responsibility
-Prescribing in the public health context
Theory based assessment -A portfolio that demonstrates application of theory to practice
-Assessment of observed practice: a systematic and detailed examination of practice
within a simulated learning environment (e.g. Objective Structured Clinical
Examination, OSCE) or a relevant live practice setting (including a video)
-A final written exam of 20 short answer and multiple choice pharmacological
questions (must achieve 80% to pass)
-Numerical assessment (must achieve 100% to pass)
-Successfully write out a prescription that requires a drug calculation
Practice based assessment Complete 12 days of supervised practice and obtain sign off from the DMP and
employer that the student is competent to prescribe medicines in their area of practice
*Office of Qualifications and Examinations Regulation (2013).
UK, United Kingdom, DMP, designated medical practitioner, CPD, continuing professional development.
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This was a cross-sectional national survey of NMP using
questionnaires distributed to two groups: (a) nurse indepen-
dent prescribers; and (b) NMP leads across nine of the 10
Strategic Health Authority areas in England (SHAs man-
aged the NHS locally and were responsible for delivering
high quality health care, developing plans for improving
and increasing the capacity of health services in their local
area).
Sample
A random sample of approximately 10% (N = 1492) of all
NIPs registered for 6 months or more as a prescriber and
residing in England were invited to participate in the NIP
questionnaire. Participants were selected from the NMC
register.
One hundred and sixty-eight NMP leads across the nine
SHAs in England were invited to participate. Trust NMP
leads were identified by SHA leaders and publically avail-
able records. The sample was stratified according to SHA
and type of Trust to ensure a national representation of all
Trust types. A 50% sample of Trust leads from acute foun-
dation/acute NHS (hospital) and primary care Trusts was
randomly selected. The total number was lower than the
number of Trusts in England (225 acute care + 153 pri-
mary care Trusts) for three reasons: one of the 10 SHAs in
England did not participate; some NMP leads covered more
than one Trust; and some Trusts did not have an NMP lead
(either permanently or temporarily).
A decision was made by the research team to invite all
NMP leads for mental health Trusts and care Trusts (who,
at the time, were organizations providing integrated health
and social care) to take part due to the smaller numbers of
these Trusts – a 50% sample would not have provided
sufficient response for meaningful analysis.
Ethical considerations
The Southampton and SW Hants Research Ethics Com-
mittee classified the surveys as service evaluation and
hence the Research Ethics Committee approval was not
required. However, all participation was voluntary and
consent was implied by the completion of the question-
naires. All participants were informed that their responses
were anonymous and confidential. All study data have
been kept in accordance with the Data Protection Act
(1998).
Data collection
The NIP questionnaire gathered information on demo-
graphics, NIP educational preparation, prescribing experi-
ence, clinical governance, risk management, opinion of
NMP and views on support and CPD (please see final
report by Latter et al. 2010 for a copy of the question-
naire). The questionnaire and study information was sent
by mail by the NMC on behalf of the research team during
November 2008. Two follow-up reminders were sent to
non-responders in December 2008–January 2009.
The NMP leads questionnaire collected regional data on
clinical governance and risk management strategies in oper-
ation and provision of CPD opportunities (please see final
report by Latter et al. 2010, for a copy of the question-
naire). NMP leads were sent an email invitation to partici-
pate in the questionnaire by either using a web-link to an
online questionnaire or via a telephone interview with a
researcher (who contemporaneously entered the data into
the online questionnaire).
All non-responders were followed up by email and tele-
phone if they had not contacted the researcher to arrange a
telephone interview or completed the online questionnaire.
Up to four follow ups were conducted at 2-week intervals.
Data analysis
All data were entered into Survey Monkey (SurveyMonkey
2008), downloaded into Excel then imported to the Statistical
Package for the Social Sciences (SPSS) Version 18 (Chicago,
IL, USA). The data were cleaned and checked by the study
researcher (AS). Frequencies and cross-tabulations were com-
pleted on the data.
Validity
Both questionnaires were developed using previously vali-
dated data collection tools; the NIP questionnaire was from a
previous national questionnaire of nurse prescribers (Latter
et al. 2007) and selected items from the Bissell et al. (2008)
national questionnaire of supplementary prescribers. Input
from the study’s advisory group also informed the design of
the NIP questionnaire. The NMP leads questionnaire drew
on issues identified from policy on NMP, the research litera-
ture and used existing tools for assessment of NMP (Royal
Pharmaceutical Society of Great Britain 2007, NHS London
2008). Piloting was undertaken by 30 NIPs and 10 NMP
leads in August 2008 to ensure the face validity of the infor-
mation collected and readability. The NMP leads question-
naire was modified in response to issues raised and some
questions were re-worded where clarification was required.
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Results
Demographics
The demographics of the NIP questionnaire cohort have
been reported elsewhere (Latter et al. 2010). Nine hundred
and seventy-six responses were received (65% response
rate), of these 840 were currently prescribing as a NIP and
were eligible to complete the full questionnaire. Nurses
were prescribing in a variety of settings across primary and
secondary care and for a wide range of health conditions.
Eighty seven NMP Trust leads completed the question-
naire (52% response rate) with all Trust types represented,
including 33% of acute care and 30% of primary care sam-
pled Trusts. Ninety nine per cent of Trust leads were
responsible for nurse prescribing, 71% for pharmacist
prescribing and 53% were responsible for allied health
professional prescribing in their Trust.
Preparatory education for prescribing
Forty nine per cent of NIPs had completed their indepen-
dent prescribing course prior to the policy changes in 2006
and with the exception of community matrons (N = 38,
67%), health visitors (N = 13, 59%) and district nurses
(N = 12, 71%), over 80% of all NIPs reported that they
were able to demonstrate their pre-requisite assessment and
diagnosis skills before the prescribing training course.
Approximately half of the NIPs (N = 386, 56%) did this
using continued assessment in the work place and 273
(40%) via formal training as part of a previous or concur-
rent award.
Five hundred and twenty (62%) NIPs completed a uni-
professional course which was set at a Bachelor’s degree
level (75%) (Office of Qualifications & Examinations Reg-
ulation 2013). NIPs generally viewed their initial prescrib-
ing courses as fit-for-purpose; the majority of NIPs (87%)
reported that their training course ‘completely’ or ‘largely
met’ both their learning needs (N = 730) and the stated
learning outcomes (N = 730). Over two-thirds of NIPs
reported they were adequately prepared by their course for
all key prescribing competencies (Table 2).
The period of supervised learning in practice with desig-
nated medical practitioners (DMP: a medical doctor who
provides training, support and supervision to the trainee
NMP and who signs off on competencies) was a positive
experience for most NIPs and the majority (N = 730, 87%)
reported receiving at least the 12 days required. With the
exception of some community matrons (N = 13, 23%) and
district nurses (N = 5, 29%), most NIPs (N = 757, 90%)
reported that it was easy to identify a DMP, facilitated by
the large majority of NIPs (N = 753, 90%) who already
knew and were working with their DMP before their
course.
Clinical governance
A majority of NMP leads reported having most key qual-
ity assurance and risk management strategies in place for
NMP (Table 3) in their Trust/s. On average, 62% of Trust
leads reported having an NMP committee, mental health/
foundation Trust leads were the least likely to report hav-
ing one. Systems for dealing with poor performance of
NMPs were more frequently reported for secondary than
primary care Trusts. Most Trust leads did not have a sys-
tem to ensure continuity of NMP services by covering
annual leave, sickness or other absences. Supported access
to electronic prescribing and computer decision support
was reported by less than a quarter of NMP leads in
acute/foundation and mental health/foundation Trusts.
This reflects the lack of electronic prescribing systems in
hospitals generally. Systems for monitoring prescribing
were reported by less than two-thirds of acute/foundation
and mental health/foundation Trusts and were less preva-
lent than in primary care. In contrast, participation in clin-
ical audit was reported by a lower percentage of NMPs
leads in primary care. Leads from all Trust types reported
relatively low rates of monitoring patient experience as a
quality assurance method. When asked whether the quality
assurance methods were different than those used to moni-
tor the practice of doctors with whom they worked,
506% of NIPs reported that they did not know, 385%
said ‘no’ and 11% stated that they were different. Com-
Table 2 Reported adequacy of the course in preparing NIPs in
specific competencies (N = 840).
Competencies (Nursing & Midwifery Council 2006) % Adequate
Consultation, decision-making and therapy
including referral
83
Influences on and psychology of, prescribing 887
Prescribing in a team context 765
Clinical pharmacology, including the effects
of co-morbidity
81
Evidence based practice and clinical governance
in relation to nurse prescribing
913
Legal, policy and ethical aspects 954
Professional accountability and responsibility 976
Prescribing in the public health context 738
NIP, nurse independent prescriber.
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ments on the difference mainly referred to more auditing
of the NIP’s practice and the lack of monitoring of doc-
tors’ practice in many instances.
Support and appraisal
The majority of NMP leads reported support mechanisms
being in place for prescribers, with the exception of access
to computer & decision support, as noted above (Table 3).
Figure 1 shows that this experience of support was reflected
by most (N = 650, 77%) NIPs, who reported having sup-
port/supervision from an experienced prescriber or access to
a network of non-medical prescribers (N = 643, 76%).
Almost three-quarters (N = 609, 73%) of NIPs said they
had a regular appraisal which included their prescribing
role.
Some NIPs may have lacked some important strategies
for formally reviewing their prescribing-related needs. Of
the 28% (N = 231) of those who stated that they did not
have an appraisal that included their prescribing role, 74%
(N = 171) did not have a personal development plan that
included prescribing and 74% (N = 171) reported never
having a session to review their independent prescribing
practice with a medical prescriber. However, 62%
(N = 143) of this group did report having access to ongoing
support from an experienced prescriber.
As a collective group (N = 96), those nurses who worked
across several different GP practice teams – district nurses,
community matrons and health visitors, were less likely to







Organizational systems for NMP
Current database of NMPs 100% 100% 100%
NMP Committee 63% 74% 50%
Clear lines of responsibility and accountability 96%* 97%* 95%
Mechanism for selecting candidates for training 96% 94% 93%
Able to identify which NMPs are prescribing 88% 92% 90%
NMPs have an agreed scope of practice 75% 85%† 95%
NMP is included in job description/contract 75%‡ 80%† 75%
System for dealing with poor performance 67%† 86%† 90%
Consideration has been given to cover for absence, etc. 38%‡ 37%§ 10%†
Policies and systems for safety information
System to disseminate safety information to NMPs 96% 91% 90%
System for learning from adverse incidents 96% 89% 100%
Policy on reporting of adverse events including to NPSA 96%* 94% 100%
NMP policies by Trust
Up-to-date NMP policy 96% 97% 95%
Up–to-date controlled drug policy 83%† 94%* 80%
Policy on unlicensed & off-label prescribing 83% 100% 90%
Supervision and support for NMPs
Support for newly qualified prescribers 88% 83% 80%
NMPs receive appropriate support or supervision 75%† 80%* 95%
NMPs are supported for access to computer & decision support 71%* 23%¶ 35%†
Systems for assuring quality of NMP
Systems for monitoring prescribing 79%† 60%† 65%†
Participation in clinical audit 50%‡ 66%† 60%†
Monitoring of patient experience 21%* 14%* 30%*
*One respondent didn’t know.
†Two respondents didn’t know.
‡Three respondents didn’t know.
§Four respondents didn’t know.
¶Five respondents didn’t know.
**Data from one care trust participant not included.
PCT, primary care trust, NMP, non-medical prescribing, NPSA, national patient safety agency.
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report access to support and supervision than the NIP
cohort as a whole. Only 52% (N = 50) of these nurses
reported having a regular appraisal, 41% (N = 39) a per-
sonal development plan, 55% (N = 53) access to an experi-
enced prescriber and 69% (N = 66) access to a network of
non-medical prescribers (Figure 1).
All NIPs reported using a range of quality assurance tools
and methods in their practice, including; monitoring of
their prescribing data (N = 568, 68%), peer review
(N = 438, 52%), use of personal records (N = 438, 52%),
case audit in a specific clinical area (N = 334, 40%) and
significant event analysis (N = 326, 39%) with less using
patient/service user questionnaires (N = 251, 30%).
Continuing professional development and decision
support
All NIPs reported using several strategies to ‘keep up-to-date’
with their prescribing, with the most common being use of
the British National Formulary (a reference which provides
up-to-date guidance on prescribing, dispensing and adminis-
tering medicines) and internet (Table 4). The majority of
NIPs reported having support from their practice/directorate/
department for continuing professional development in the
form of study leave (N = 658, 78%), in-house training
courses (N = 599, 71%) and just over half of nurses reported
access to a budget for external training courses (N = 492,
58%). Approximately one-third, 305% (N = 18) of NMP
leads reported that the CPD provided by the Trust was not
adequate to maintain patient safety. Eighteen per cent
(N = 152) of NIPs, reported that their CPD activities were
not adequate to maintain patient safety. There was no statis-
tically significant relationship between NIP job title and the
reporting of inadequate CPD, however, this was reported by
a higher number (N = 25) of the collective group (N = 96) of
district nurses, health visitors and community matrons.
In all, 588 NIPs (70%) reported how they prepared them-
selves for prescribing competence in a new area. Twenty
eight per cent said they had not prescribed in a new area
since completing the independent prescribing course. Of
those NIPs who had moved into a new clinical area, the
majority (N = 482) reported using multiple methods to pre-
pare themselves. The most frequently reported method was
undertaking courses/training (N = 159, 25%). Eighteen per






























































































Figure 1 Percentage of NIPs who have
access to prescriber support, appraisal
and development.
Table 4 NIPs’ sources for keeping up-to-date.
Source NIPs (n)
British National Formulary 952% (800)
Using the internet 786% (660)
Peer network 773% (649)
Reading peer-reviewed journals 632% (531)




Electronic Information Resource (NPCi)
449% (377)
National Prescribing Centre NMP sessions 443% (372)
Pharmaceutical industry representatives 379% (318)
National Electronic Library for Health 352% (296)
National Electronic Library for Medicines 317% (266)
Other 155% (130)
NIP, nurse independent prescriber; NMP, non-medical prescribing.
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using various resources, including: internet, professional
magazines, journals and text books. Of the 17% (N = 106)
who reported using guidelines, these included National Insti-
tute for Health and Clinical Excellence (NICE), NHS clini-
cal knowledge summaries (CKS) and Trust protocols/
guidelines. Approximately a third (N = 227) of NIPs
reported the use of more experiential methods of achieving
competence – discussion/meetings/forums with colleagues,
clinical supervision and observing/shadowing colleagues.
Discussion
Education
It appears that, since the opening up of the formulary to
enable a potentially much greater scope of medicines to be
prescribed for a wider range of conditions, NIPs have
remained largely satisfied with their initial education and
felt well prepared to prescribe in their clinical area. This is
consistent with previous research into earlier cohorts of
nurses prescribing from a less extensive formulary (Latter
et al. 2007) and pharmacist independent prescribers (Coo-
per et al. 2008). This finding suggests that the UK model of
nurse prescriber training, although comparatively short
compared with other countries where NMP is aligned to
nurse practitioner or other advanced practice education,
was considered adequate by nurse prescribers to prepare
them. This finding is pertinent to ensure that those who
train begin and continue to prescribe and that the resources
allocated to this education have the potential to impact on
patient care (Stewart et al. 2012).
Bradley et al. (2006) identified previous concern around
nurses’ inadequate pharmacological knowledge; this does
not appear to be reflected by the views of NIPs in this
study, most of whom reported adequate preparation in this
area. This may reflect a real change in nurse prescribers’
pharmacological knowledge due to changes made by Higher
Education Institutions in response to increased awareness of
this issue and use of innovative methods of teaching to
overcome these barriers (Lymn & Mostyn 2010). Alterna-
tively, this positive finding may be a limitation of the self-
report nature of the data.
Clinical governance
This finding that there are mechanisms in place by which the
quality and safety of NMP is being monitored and managed
at Trust level is reassuring. Some trust did lack some policies
and clinical governance strategies, these Trusts may have had
fewer non-medical prescribers in place and demand may help
to drive improvements in this area as the numbers of all
NMPs, including allied health professionals, continues to
increase across the UK (Courtenay et al. 2011b).
Turnover of NMP leads may be an explanatory factor;
Courtenay et al. (2011a) reported 21% of those inter-
viewed in 2009 had been in their position for less than
6 months-1 year. High turnover rates or vacancies could
hinder local policy and governance development, leading to
some of the inconsistencies seen across Trusts both in our
study and a single region study conducted a year later (Lim
et al. 2012).
Systems for monitoring prescribing were reported by a
higher percentage of NMP leads in primary care, where
there is routine access to electronic prescribing analysis and
cost data (ePACT). The reverse was the case for participa-
tion in clinical audit which was more widely reported in
acute (secondary) care. Lack of access to electronic pre-
scribing data in secondary care was suggested as the reason
for uncertainty among NMP leads about whether audit and
review of NMP services was taking place (Lim et al. 2012).
Lim and colleagues suggested that NMP leads could work
more closely with the experienced clinical governance teams
in secondary care Trusts to improve oversight of NMP. The
importance of this was highlighted by Courtenay et al.
(2011a) who found that non-medical prescribers have over-
come difficulties with support for prescribing in Trusts that
have NMP strategies in place and where NMP is more
entrenched in the organization.
Support and appraisal
Three-quarters of the NMP leads in this study reported that
NMPs were receiving appropriate support or supervision –
a similar proportion was found in a study conducted 1-year
later (Lim et al. 2012). There was however, a group of
potentially vulnerable NIPs who, less frequently reported
having access to sufficient support and supervision than
other nurse prescribers: district nurses, community matrons
and health visitors. Nurses in this group were also more
likely to report an inability to demonstrate the pre-requisite
assessment and diagnosis skills before the prescribing
course. Previous research in this group has highlighted lim-
ited support from general practice and the healthcare envi-
ronment as a whole (While & Biggs 2004).
This may be due to the nature of these roles, where nurses
are working across multiple settings with multiple teams
and general practices, dissipating the responsibility for these
crucial connections, support and reflection that are needed
to maintain the quality and safety of prescribing (Humphries
& Green 2000). This finding may also reflect the importance
8 © 2014 John Wiley & Sons Ltd
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of team support for prescribing after qualifying (Latter et al.
2007). These groups of nurses may also have limited access
to patient records when assessing, diagnosing and prescrib-
ing in the patient’s home environment. Combined with the
fact that community matrons are responsible for pharmaco-
logical management of complex, vulnerable patients with
co-morbidities and taking multiple medicines (Department
of Health 2005), this finding gives some cause for concern.
Further research is required to understand the specific diffi-
culties these prescribers may be experiencing and the impact
of this on the safety and quality of their prescribing. From a
policy implementation point of view, it has been suggested
that the lack of support and difficulties associated with com-
munity nurse prescribers affects clinical practice and may
decrease the desire to become and/or continue prescribing in
these roles (Hall et al. 2006).
Continuing professional development and decision
support
The majority of Trusts appear to provide these opportuni-
ties and this indicated an improved picture from previous
research on NIPs (Latter et al. 2007) and reflected similar
results to Carey and Courtenay (2010). Results also
suggest that the group of NIPs working across teams in
primary care may have had less access to the support and
CPD reported by the majority in other settings; this is con-
sistent with other NIP CPD research (Green et al. 2009,
Downer & Shepherd 2010). General barriers to CPD for
all types of NIPs have been identified such as lack of staff
cover, other work commitments, lack of support from
managers and pressure to satisfy mandatory updates
(Green et al. 2009). It is thought that this lack of support
may lead to a lack of confidence in prescribing (Downer
& Shepherd 2010), which is of significant concern as there
are over 30,000 community nurse practitioners and non-
medical prescribers in the UK (Culley 2010). It is unknown
why this group in particular had difficulty in assessing
CPD and further research across a larger sample is recom-
mended here.
Despite the generally positive finding of having access to
CPD and reports of nurses keeping up-to-date, the finding
that 18% of NIPs and 31% of NMP leads considered that
exposure to CPD was not sufficient to ensure patient safety
is of concern. Consistent with findings reported above,
greater proportions of community nurses – district nurses,
health visitors and community matrons – reported this con-
cern. Given the potential significance of this issue, further
research is also required to explore this further.
While international comparisons should be made with
caution due to differences in legislative and professional
jurisdiction arrangements on NMP, similar themes of satis-
factory education for prescribing, confidence to prescribe
and the need for further development of continuing educa-
tion and support for nurses, especially those in rural or
community prescribing settings have emerged in Australia,
New Zealand, the Netherlands, Ireland and Canada (Spence
& Anderson 2007, Elsom et al. 2008, Kroezen et al. 2011).
International comparative studies may provide further
insight into this common finding.
Study strengths and limitations
Why is this research or review needed?
• There has been little published research into the educa-
tional preparedness of nurse independent prescribers fol-
lowing the introduction of extended prescribing authority
for nurses in 2006.
• Little was known about the extent to which the Depart-
ment of Health (England) non-medical prescribing policies
and guidance on support for and oversight of, non-medical
prescribing are being implemented nationally in England.
What are the three key findings?
• Nurse independent prescribers reported that a short educa-
tional course provided adequate preparation for prescribing
and was fit-for-purpose.
• Most core quality assurance mechanisms and management
processes to enable non-medical prescribing were in place,
exceptions being monitoring patient experience, quality
assuring prescribing and ensuring continuity of non-medi-
cal prescribing services.
• Community based nurses (district nurses, community
matrons and health visitors) less frequently reported having
access to sufficient support and supervision than other
nurse prescribers.
How should the findings be used to influence policy/
practice/research/education?
• To ensure competence, monitoring of education and
continuing professional development is important as non-
medical prescribing develops further.
• Prescribing leaders may help to ensure continuity of non-
medical prescribing services for patients and to ensure that
their views on non-medical prescribing services are taken
into account as part of service evaluation and development.
• Community based nurses who are prescribing need new
innovative systems to ensure they have appropriate support
and education opportunities.
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To our knowledge, this was the first and largest national
study of the implementation of these important safety and
quality mechanisms for NMP in the wake of the 2006
changes, at both organizational and individual practitioner
level. The NIP questionnaire sample included approximately
10% of all registered NIPs, selected using random sampling
and with its response rate of 65%, can be considered nation-
ally representative for England. The NMP leads question-
naire response rate, 52%, means it may not be possible to
generalize to all Trusts in England. Findings may not be
generalizable to other parts of the UK. The questionnaires
are also subject to the limitations of self-reported data.
Conclusion
This research provides baseline findings around education and
governance of nurse prescribing that future research or
changes in policies can comparatively measure against. Inter-
nationally, it is acknowledged that further research is required
to ‘confirm that nurse prescribers are well prepared and able
to use effective decision-making processes for safe prescrib-
ing’, the methods and procedures presented here provide vali-
dated tools that can be used to implement such studies (Lim
et al. 2007). It also suggests that short stand-alone courses are
sufficient to prepare nurse independent prescribers.
The impact on policy and practice is of considerable sig-
nificance. As of April 2013, the NHS in England restruc-
tured primary care trusts into clinical commissioning
groups (CCGs), these structures will collaboratively manage
primary care contracting with the local community (Depart-
ment of Health 2013). As a result of this change, many
CCGs will review or establish policies including that of
NMP. This research provides evidence that educational
preparation was considered by nurse prescribers to be fit-
for-purpose and that most NHS trusts (primary and second-
ary) had established core clinical governance and manage-
ment strategies for non-medical prescribing and, therefore,
may not need extensive change or review. The findings also
highlight examples that may enhance practice, for example,
providing support mechanisms for community nurses or
apportioning funds to increase CPD opportunities. Alterna-
tively, it may be that as NMP becomes more established,
specific governance, separate from that of medical prescrib-
ing, may be seen as less necessary. Indeed, there have been
moves to combine competencies required for prescribing
across medical and non-medical prescribers (National Pre-
scribing Centre 2013).
Lessons taken from this research could be drawn on by
countries currently developing NMP to establish policies
from the outset that enhance practice, such as improved
incorporation of community/rural nurses into the healthcare
team. Further research in England is needed to examine the
disparities observed in support experienced by commu-
nity nurses. Attention is also needed to understand how
mechanisms for oversight and quality monitoring of
prescribing are applied in this group. We suggest that the
experiences of this group of nurse prescribers warrant
further investigation both in England and internationally.
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